These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18540685)
21. Functionalized magnetic nanoparticles as vehicles for the delivery of the antitumor drug gemcitabine to tumor cells. Physicochemical in vitro evaluation. Viota JL; Carazo A; Munoz-Gamez JA; Rudzka K; Gómez-Sotomayor R; Ruiz-Extremera A; Salmerón J; Delgado AV Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1183-92. PubMed ID: 23827558 [TBL] [Abstract][Full Text] [Related]
22. Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues. Caron J; Reddy LH; Lepêtre-Mouelhi S; Wack S; Clayette P; Rogez-Kreuz C; Yousfi R; Couvreur P; Desmaële D Bioorg Med Chem Lett; 2010 May; 20(9):2761-4. PubMed ID: 20363623 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of core-shell gold coated magnetic nanoparticles and their interaction with thiolated DNA. Robinson I; Tung le D; Maenosono S; Wälti C; Thanh NT Nanoscale; 2010 Dec; 2(12):2624-30. PubMed ID: 20967339 [TBL] [Abstract][Full Text] [Related]
24. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876 [TBL] [Abstract][Full Text] [Related]
25. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System. Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660 [TBL] [Abstract][Full Text] [Related]
26. Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. Reddy LH; Marque PE; Dubernet C; Mouelhi SL; Desmaële D; Couvreur P J Pharmacol Exp Ther; 2008 May; 325(2):484-90. PubMed ID: 18258784 [TBL] [Abstract][Full Text] [Related]
27. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy. Trung Bui D; Maksimenko A; Desmaële D; Harrisson S; Vauthier C; Couvreur P; Nicolas J Biomacromolecules; 2013 Aug; 14(8):2837-47. PubMed ID: 23829862 [TBL] [Abstract][Full Text] [Related]
28. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Couvreur P; Reddy LH; Mangenot S; Poupaert JH; Desmaële D; Lepêtre-Mouelhi S; Pili B; Bourgaux C; Amenitsch H; Ollivon M Small; 2008 Feb; 4(2):247-53. PubMed ID: 18247384 [TBL] [Abstract][Full Text] [Related]
29. Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles. Arias JL; Ruiz M; Gallardo V; Delgado AV J Control Release; 2008 Jan; 125(1):50-8. PubMed ID: 17949844 [TBL] [Abstract][Full Text] [Related]
30. Simple synthesis of functionalized superparamagnetic magnetite/silica core/shell nanoparticles and their application as magnetically separable high-performance biocatalysts. Lee J; Lee Y; Youn JK; Na HB; Yu T; Kim H; Lee SM; Koo YM; Kwak JH; Park HG; Chang HN; Hwang M; Park JG; Kim J; Hyeon T Small; 2008 Jan; 4(1):143-52. PubMed ID: 18189246 [TBL] [Abstract][Full Text] [Related]
31. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery. Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272 [TBL] [Abstract][Full Text] [Related]
32. Peptide conjugation: before or after nanoparticle formation? Valetti S; Mura S; Noiray M; Arpicco S; Dosio F; Vergnaud J; Desmaële D; Stella B; Couvreur P Bioconjug Chem; 2014 Nov; 25(11):1971-83. PubMed ID: 25313527 [TBL] [Abstract][Full Text] [Related]
33. Squalenoylation: a generic platform for nanoparticular drug delivery. Desmaële D; Gref R; Couvreur P J Control Release; 2012 Jul; 161(2):609-18. PubMed ID: 21840355 [TBL] [Abstract][Full Text] [Related]
34. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy. Maksimenko A; Alami M; Zouhiri F; Brion JD; Pruvost A; Mougin J; Hamze A; Boissenot T; Provot O; Desmaële D; Couvreur P ACS Nano; 2014 Mar; 8(3):2018-32. PubMed ID: 24555414 [TBL] [Abstract][Full Text] [Related]
36. Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells. Trabulo S; Aires A; Aicher A; Heeschen C; Cortajarena AL Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1597-1605. PubMed ID: 28161480 [TBL] [Abstract][Full Text] [Related]